Patent details

Basic Information

Publication number:

EP4259093

PCT Application Number:

IB2021061499

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP218246833

PCT Publication Number:

WO2022123480

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MATERIAL AND METHOD FOR TREATING CANCER

French Title of Invention:

MATÉRIAU ET MÉTHODE DE TRAITEMENT DU CANCER

German Title of Invention:

MATERIAL UND VERFAHREN ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

09/12/2021

Grant date:

13/08/2025

EP Publication Date:

18/10/2023

PCT Publication Date:

16/06/2022

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/08/2025

EP B1 Publication Date:

13/08/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

09/12/2041

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/08/2025

 

 

Name:

UroGen Pharma Ltd.

Address:

9 Ha'Ta'asiya St., 4365007 Ra'anana, Israel (IL)

Inventor

1

Name:

KONORTY, Marina

Address:

Israel (IL)

2

Name:

TSIPORI, Omer

Address:

Israel (IL)

3

Name:

HIONIDI, Yulia

Address:

Israel (IL)

Priority

Priority Number:

202063124111 P

Priority Date:

11/12/2020

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/06; A61K 9/19; A61K 31/407;

Publication

European Patent Bulletin

Issue number:

202533

Publication date:

13/08/2025

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/06/2026

Annual Fee Number:

5

Annual Fee Amount:

52 Euro

Penalty Fee Amount:

20 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages